Red Laser Cyclophotocoagulation for Treatment of Therapy-Resistant Glaucoma
Total Page:16
File Type:pdf, Size:1020Kb
Department of Ophthalmology University of Helsinki Helsinki, Finland View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto Red Laser Cyclophotocoagulation for Treatment of Therapy-resistant Glaucoma Virpi Raivio Academic dissertation To be publicly discussed, by the permission of the Medical Faculty of the University of Helsinki, in the Auditorium of the Department of Ophthalmology, Haartmaninkatu 4, Helsinki, on October 11th, 2002, at 12 o´clock noon. Helsinki 2002 Supervised by: Docent Ilkka Immonen, MD Department of Ophthalmology University of Helsinki, Finland and Päivi Puska, MD Department of Ophthalmology University of Helsinki, Finland Reviewed by: Professor (emer.) Ahti Tarkkanen, MD Department of Ophthalmology University of Helsinki, Finland and Docent Berit Calissendorff, MD Karolinska Institutet Stockholm, Sweden Discussed with: Professor Roger Hitchings, MD University College London London, UK © Virpi Raivio ISBN 952-91-4972-7 (nid.) ISBN 952-10-0632-3 (verkkojulkaisu, pdf) http://ethesis.helsinki.fi Helsinki 2002 Yliopistopaino Contents ABBREVIATIONS ................................................................................................................................... 7 LIST OF ORIGINAL PUBLICATIONS ................................................................................................. 8 1. INTRODUCTION ............................................................................................................................... 9 2. REVIEW OF THE LITERATURE 2.1. Glaucoma .................................................................................................................................... 10 2.1.1. Definition ......................................................................................................................... 10 2.1.2. Treatment options............................................................................................................. 10 2.2. Cyclodestruction.......................................................................................................................... 11 2.2.1. The pre-laser era of cyclodestruction ............................................................................. 11 2.2.2. Cyclophotocoagulation..................................................................................................... 11 History......................................................................................................................................... 11 Laser delivery to the ciliary body .............................................................................................. 11 Scleral transillumination ........................................................................................................... 12 Non-contact Nd:YAG laser CPC .............................................................................................. 12 Contact CPC .............................................................................................................................. 12 The contact probe ............................................................................................................ 12 Contact Nd:YAG laser CPC ............................................................................................ 13 Contact 810 nm diode laser CPC ................................................................................... 13 Contact red laser CPC ..................................................................................................... 13 Laser transmission and absorption ........................................................................................... 14 Mechanisms of IOP decrease .................................................................................................... 15 Morphological changes observed in the ciliary body epithelium, the stroma and the ciliary body vasculature ...................................................................................................... 16 The Nd:YAG laser .......................................................................................................... 16 The 810 nm diode laser ................................................................................................... 16 The visible red lasers ....................................................................................................... 17 Morphological changes observed elsewhere ............................................................................ 17 The conjunctiva ............................................................................................................... 17 The sclera ........................................................................................................................ 17 The ciliary muscle ........................................................................................................... 18 The iris, the lens, the intraocular lens, and the zonules .................................................. 18 Sympathetic ophthalmia.................................................................................................. 19 The retina ........................................................................................................................ 19 Mechanisms of treatment failure ............................................................................................... 19 Clinical outcome of cyclophotocoagulation .............................................................................. 20 Heterogeneous glaucoma population .............................................................................. 20 3 Posttraumatic glaucoma .................................................................................................. 20 Glaucoma in children and young adults .......................................................................... 22 Neovascular glaucoma .................................................................................................... 23 Corneal complications after cyclophotocoagulation ...................................................... 23 3. AIMS OF THE STUDY ..................................................................................................................... 26 4. PATIENTS AND METHODS ........................................................................................................... 27 4.1. Patients .................................................................................................................................... 27 4.1.1. Transscleral Contact Krypton Laser Cyclophotocoagulation for Treatment of Posttraumatic Glaucoma (I) ....................................................................................... 27 4.1.2. Transscleral Contact Krypton Laser Cyclophotocoagulation for Treatment of Glaucoma in Children and Young Adults (II) ............................................................ 29 4.1.3. Transscleral Red Laser Cyclophotocoagulation Combined with Limited Anterior Retinal Cryocoagulation in Neovascular Glaucoma (III) ............................................. 31 4.1.4. Corneal Innervation, Corneal Mechanical Sensitivity, and Tear Fluid Secretion after Cyclophotocoagulation with the Transscleral Contact 670 nm Diode Laser (IV) ........ 32 4.2. Methods .................................................................................................................................... 33 4.2.1. Clinical ophthalmological examination .......................................................................... 33 4.2.2. Cyclophotocoagulation ............................................................................................... 33 4.2.3. Limited anterior retinal cryocoagulation ........................................................................ 34 4.2.4. Definitions of success and failure.................................................................................... 35 4.2.5. In vivo confocal microscopy ............................................................................................ 35 4.2.6. The measurement of corneal sensitivity........................................................................... 35 4.2.7. The measurement of the rate of tear fluid secretion ....................................................... 36 4.2.8. Statistical methods ............................................................................................................ 36 5. RESULTS ..................................................................................................................................... 37 5.1. Transscleral Cyclophotocoagulation with the Contact Krypton Laser for Treatment of Posttraumatic Glaucoma (I) ....................................................................................................... 37 5.1.1. Success of IOP................................................................................................................. 37 5.1.2. Glaucoma medication ...................................................................................................... 38 5.1.3. Visual acuity .................................................................................................................... 38 5.1.4. Complications .................................................................................................................. 39 5.2. Transscleral Cyclophotocoagulation with the Contact Krypton Laser for Treatment of Glaucoma in Children and Young Adults (II)